Investor Relations
Investor Presentation
View our latest Investor Presentation to find the most recent investor-related information.
Sign up today and receive company updates straight to your inbox.
Virax Biolabs is a Biotech and disruptive Medical Technology company focused on the prevention, detection and diagnosis of Viral threats. Our mission is the global provision of high-quality diagnostic kits, particularly T-Cell tests, which accurately and effectively predict an individual's immune response to significant viral threats. Our proprietary diagnostic T-cell technologies are virus agnostic, offering high levels of transparency, information and insight in a cost-efficient way. Key product ranges include ViraxClear, ViraxCare and flagship product being released 2022, Virax Immune.
Virax Biolabs Group Limited
20 North Audley Street
London W1K 6LX
United Kingdom
T: +44 20 7788 7414
info@viraxbiolabs.com
Russo Partners, LLC
Maxim Jacobs, CFA
12 West 27th Street
4th Floor
New York, NY 10001
M: 646-942-5591
Maxim.Jacobs@russopartnersllc.com
Continental Stock Transfer
Charlotte Hewitt
1 State Street
30th Floor
New York, NY 10004
T: 212-857-7577
chewitt@continentalstock.com